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Abstract
The effect of acute blood glucose elevations on human outer retinal function was examined. Electrooculograms were recorded
as the background light cycled on:off with a 2-min period, eliciting rapid changes in the corneo-retinal standing potential known
as the fast-oscillation of the electrooculogram. Recordings were made while subjects fasted and after they consumed 100 g of
D-glucose. In all subjects, blood glucose levels strongly affected fast oscillation amplitude, which reflects photoreceptor-driven
changes in RPE cell chloride concentration. The sensitivity of RPE metabolism to glucose fluctuations may relate to changes in
the blood-retinal barrier that are known to occur in diabetes (e.g. macular edema). © 2000 Elsevier Science Ltd. All rights
reserved.
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1. Introduction
The retinal pigment epithelium (RPE), site of the
outer blood-retinal-barrier (BRB), is critical for normal
function of the photoreceptors and for control of fluid
volume and ionic concentrations in the subretinal
space. In diabetes, loss of integrity of the inner and
outer BRBs, with subsequent development of macular
edema, is the major cause of visual impairment. Failure
of the RPE to effectively move the fluid out of the
retina may contribute to the persistence and progres-
sion of macular edema.
Although the full manifestations of BRB breakdown
(e.g. macular edema) are usually associated with ad-
vanced retinopathy, deterioration of the BRB actually
begins at a very early stage. In fact, studies employing
vitreous fluorophotometry (VFP) have shown it to be
one of the earliest ocular functional lesions that can be
detected in human and experimental diabetes, occurring
prior to the development of ophthalmoscopic or angio-
graphic signs of retinopathy. (Cunha-Vaz, Faria de
Abreu, Campos, & Figo, 1975; Waltman et al., 1978;
Schalnus & Ohrolff, 1995; Benitez del Castillo, Castillo,
Fernandez, & Garcia-Sanchez, 1993). Abnormally ele-
vated VFP values have also been shown to correlate
with the degree of diabetic retinopathy, predict further
breakdown of the BRB, predict the development and
progression of retinopathy, as well as herald the need
for future laser-photocoagulation therapy (Castillo et
al., 1996; Krupin & Waltman, 1985; Benitez del Castillo
et al., 1993; Cunha-Vaz, Leite, Sousa, & Faria de
Abreu, 1993; Cunha-Vaz et al., 1998; Engler, Krogsaa,
& Lund-Andersen, 1991). Increased VFP values are
associated with increased duration of diabetes and ele-
vated glycated hemoglobin values (a measure of poor
long-term control of blood glucose), suggesting that
this functional abnormality is directly related to chronic
hyperglycemia (Castillo et al., 1996). Reversal of abnor-
mal VFP results can be achieved with improvement of
blood glucose control (White, Waltman, Krupin, &
Santiago, 1982; Bleicher et al., 1980), providing addi-
tional evidence that early breakdown of the BRB is
directly related to hyperglycemia.
Several studies of experimental diabetes have demon-
strated that structural and functional alterations of the
RPE precede changes in the retinal vasculature (inner-
BRB) (Kirber, Nichols, Grimes, Winegrad, & Laties,
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1980; Krupin et al., 1982; Tso, Cunha-Vaz, Shih, &
Jones, 1980; Vinores, Gadegbeku, Campochiaro, &
Green, 1989; Klein, Engerman, & Ernest, 1980). Struc-
tural signs of RPE damage include: thickening of the
basal laminae of the RPE and Bruch’s membrane,
marked dilation and redundancy of RPE basal mem-
brane infoldings, formation of large vacuoles within
RPE cells, RPE cell swelling, and focal necrosis
(Vinores et al., 1989; Grimes, McGlinn, Laties, & Naji,
1984; Grimes & Laties, 1980; Tso et al., 1980). Early
stage abnormalities of RPE barrier function have been
demonstrated using tracer elements, such as FL and
horseradish peroxidase (HRP), which appear within
and pass through RPE cells (i.e. into the sub-retinal
space) of diabetic animals, but not in non-diabetic
animals (Kirber et al., 1980, Tso et al., 1980).
In summary, animal studies show altered structure
and function of RPE membranes early in experimental
diabetes. Human clinical studies show the manifesta-
tions of this early BRB breakdown as FL accumula-
tion. Additional evidence indicates that accumulation
of FL within the human diabetic vitreous reflects dys-
function of active outward transport mechanisms for
fluid and organic anions, such as chloride and sodium
fluorescein, (e.g. Engler, Sander, Larsen, Dalgaard, &
Lund-Andersen, 1994a; Engler et al., 1994b; Tsuboi,
1990). Active transport of fluid across the RPE in the
retina to choroid direction is primarily driven by the
RPE chloride ion transport pathway, which consists of
an apical (facing the photoreceptors) membrane Na–
K–2Cl cotransporter and a basolateral (facing the
choroidal blood supply) membrane Cl channel (re-
viewed by Gallemore, Hughes, & Miller, 1997).
Changes in retinal illumination alter the activity of
the RPE chloride ion transport pathway. The molecular
events and RPE membrane voltage responses that oc-
cur in response to light onset (and offset) can be
measured non-invasively in the human eye using the
electro-oculogram (EOG, Arden & Kelsey, 1962;
Kolder & Brecher, 1966) which reflects changes in the
standing potential (or corneo-retinal potential) of the
eye. During the first minute of light onset, the standing
potential rapidly decreases and then begins a slow
steady increase lasting 8–12 min. These light-induced
changes in the standing potential are known as the ‘fast
oscillation’ and ‘slow oscillation’, respectively. Avail-
able evidence indicates that the light ‘trough’ of the
EOG fast oscillation (FEOG) is generated by a light-
evoked decrease in chloride ion (Cl) concentration
within RPE cells with subsequent hyperpolarization of
the basolateral membrane (Bialek, Joseph, & Miller,
1995; Gallemore & Steinberg, 1993).
Given the mounting evidence that abnormalities of
RPE metabolism may be an early ocular manifestation
of diabetes, as well as the important role that the RPE
chloride ion transport pathway has in moving fluid out
of the retina, we chose to use the FEOG technique to
evaluate changes in RPE function during acute
metabolic challenges common to the diabetic state.
Here we examine the sensitivity of the normal human
outer retina and retinal pigment epithelium to alter-
ations in blood glucose levels, using the fast-oscillation
of the clinical electro-oculogram. Our results show that
in normal humans, the FEOG is very sensitive to
changes in blood glucose, showing large amplitude
increases with increasing blood glucose.
2. Methods
2.1. Subjects
Nine healthy individuals (age 22–42) with no history
of eye disease or systemic disease known to affect vision
were tested.
All subjects gave written informed consent after the
experimental procedures were described to them. All
subjects were tested in accordance with the tenets of the
Declaration of Helsinki and with approval of the insti-
tutional human experimentation review board.
2.2. Electro-oculogram recording
Pupils were dilated using Phenylephrine 2.5% and:or
Tropicamide 1.0% following corneal anesthesia
(Proparacaine 0.5%). The skin was scrubbed in prepa-
ration for electrode attachment. Silver:silver chloride
electrodes filled with conductive gel were attached to
the skin with tape rings at the lateral and medial canthi
of each eye, with forehead as ground.
EOG’s were recorded using an LKC electrodiagnos-
tic system (Gaithersgurg, MD). The subject was seated
with his:her head positioned on a chin rest at the
opening of a white Ganzfeld dome. Room lights were
off during testing. For EOG recordings, two red LED’s
at the rear of the dome, separated horizontally by 30°,
were alternately lit for 2 s (4 s per left:right-right:left
saccade pair) to elicit regular fixed amplitude saccadic
eye movements (see Fig. 1A). Three hundred millisec-
onds after each saccade prompt (to allow time for
completion of the saccade), the voltage signal was
averaged from ten 30-ms epochs (total sample time:sac-
cade 300 ms). The voltage difference between left-ro-
tated and right-rotated eye positions (e.g. points labeled
b and a in Fig. 1A) were taken as the amplitude of the
standing potential at that time. The Ganzfeld dome
light (30 cd:m2) was cycled off:on at 1 min intervals for
10 min (five light:dark cycles per EOG recording) to
permit recording of the FEOG.
EOG data were analyzed using standard LKC system
software. Following smoothing and spike removal, a
sine wave (peaks occurring in dark, troughs in light
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periods) was fit to the five-cycles of raw data (Fig. 1B).
Three parameters of the sine wave are computed by the
software: amplitude, peak:trough ratio, and phase. Am-
plitude was considered in analyses reported here, be-
cause it is conceptually straightforward. The general
results and conclusions would have been the same if
peak to trough ratio were used instead. The amplitude
data from the two eyes of each subject were averaged,
as both eyes produced very similar results.
2.3. Protocol
Upon arrival, subjects were prepared for recordings,
given instructions, and practiced making eye move-
ments of appropriate timing:amplitude in response to
the LED’s.
Blood glucose was measured at the start and end of
the test session as well as between 10-min recordings.
For each measure, a blood drop was obtained by finger
stick, and glucose level was determined using a cali-
brated One-Touch glucose meter (LifeScan,
Johnson&Johnson).
Subjects were tested in the morning following
overnight fast. Thus, subjects initially had fairly low
blood glucose levels, and after two or three ‘baseline’
fasting BG and FEOG’s were recorded, the subjects
consumed a solution containing 100 g of D-glucose to
elevate BG. Subjects were required to drink the entire
glucose tolerance test solution within 5 min. BG and
FEOG recordings were then recorded alternately as BG
rose, and then, in most cases, fell (after 30 min) as a
result of the normal insulin response. Experimental
sessions lasted 1.5–2 h, including frequent breaks.
3. Results
Fig. 2, which shows results for three subjects, illus-
trates the general pattern of results for all nine subjects.
For each subject, blood glucose (open symbols, dotted
lines, right ordinates) and FEOG amplitude (solid sym-
bols and line, left ordinate) are plotted against time into
the test session. To the extent that the two curves in
each panel follow a similar pattern with similar time
course, an association between BG level and FEOG
amplitude is indicated. As expected, after subjects
drank the glucose solution (arrows), blood glucose be-
gan to rise; the rise in blood glucose was accompanied
by an increase in FEOG amplitude for all subjects. In
all but one case (Panel C), testing was continued for a
sufficiently long period so that blood glucose leveled off
or declined during the test session as a result of the
individual’s normal insulin response. FEOG amplitude
either leveled off (e.g. Panel A), or, more often, tran-
siently fell markedly (e.g. Panel B) when the increase in
blood glucose was curtailed (by endogenous insulin).
Note for the subjects whose data are shown in panels
A and B that while the excursion of FEOG amplitude
is similar (each spanning 100 mV) the absolute values
are different. Also note that the FEOG amplitudes of
the subject in panel C span a range three times that of
the others, illustrating the inter-subject variation in the
magnitude of the glucose-associated change in FEOG
amplitude. The range of blood glucose values is similar
among these three subjects, though there is somewhat
less blood glucose variation across time for the subject
in panel B.
The time course of BG change in normal subjects is
also quite consistent; BG begins to rise within just a few
minutes after glucose ingestion and continues to do so
for about 30 min. This pattern makes possible a sim-
plification of the quantitative analysis of the relation
Fig. 1. Recording the FEOG. (A) Eye movement traces (voltages
across time) for the right and left eyes of a subject who is tracking the
alternately illuminating LED’s. The gray rectangles indicate the 300
ms during which voltages are averaged following each saccade. The
voltages after each saccade are then differenced (e.g. b–a) to continu-
ously derive the amplitude of the standing potential as shown in panel
B. (B) Result from each eye of a single FEOG measurement. Dark
traces are the derived FEOG data, showing oscillations of the stand-
ing potential in response to cyclical light:dark stimulation (white and
stippled vertical bars). Values of the FEOG amplitude are computed
from the best fitting sine wave for each data set (smooth gray traces).
(C) Averaged pre-glucose (thin, black) and post-glucose (thick, gray)
FEOG’s for subject c9. Note vertical scale difference in panels B
versus C. Best fitting sine waves not shown in panel C for clarity.
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Fig. 2. Variation in FEOG amplitude (solid symbols, line; left ordinates) and blood glucose (open symbol, broken lines; right ordinates) across
time in three non-diabetic subjects (Panel A; Subject c4; Panel B, Subject c 5; Panel C, Subject c9). Note: Glucose scales are the same for
all subjects (range 40–200 mg:dl). The blood glucose values are also in mM on the panel at the right; (1 mM18.018 mg:dl). FEOG amplitude
scales vary in range among subjects; scales in panels A and B span 100 mV; panel C spans 300 mV. The relative vertical position of the two sets
of data within each panel is arbitrary. Arrows on the ordinate indicate the time at which glucose solution was administered (over a 5 min period).
between BG and FEOG amplitude. For each subject,
the mean of the amplitudes of the two to three FEOG’s
recorded prior to glucose ingestion is used to estimate
‘pre-glucose’ FEOG amplitude. The estimate of the
‘post glucose’ FEOG was obtained by averaging all
FEOG’s obtained during the period starting 10 min
after the initiation of the ingestion of the glucose solu-
tion and up to 30 min after glucose ingestion. FEOG’s
obtained within 5 min of a measured leveling off or
decline in blood glucose were excluded. The circled and
boxed points in Fig. 2 indicate the FEOG amplitudes
included in the pre-glucose and post-glucose measures,
respectively, for each of these three subjects. Fig. 1C
directly compares the averaged pre-glucose FEOG’s
and post-glucose FEOG’s for subject c9, whose data
are presented on the right in Fig. 2. The larger ampli-
tude of the averaged post-glucose (thick gray trace)
response is readily apparent.
The ratio of post- and pre-glucose FEOG amplitude
was calculated for each individual. The ratio simplifies
comparisons by eliminating large inter-individual differ-
ences in absolute FEOG amplitude (attributable to
differences in electrode placement relative to the poste-
rior pole, etc.). Fig. 3 shows the post:pre FEOG ampli-
tude ratios for the nine subjects. All fall above the line
of equal amplitude, consistent with all FEOG’s being of
larger amplitude during the period during which blood
glucose was rising. The ratios range from 1.10 to 1.65,
representing 10–65% increases in amplitude (median
25.4%, mean 28.7%).
Two subjects (c 8 and 9, who showed average and
largest glucose-associated FEOG excursions, respec-
tively) were tested in second sessions to measure the
variation of the FEOG amplitude over time in the
absence of glucose variation. For these measures water
was consumed rather than the glucose solution. Aver-
age pre-(water) and post-(water) amplitudes were com-
puted, and from them the percent change for each
person. The average percentage amplitude change over
the length of a test session in the absence of glucose was
12.3%. A second estimate of non-glucose related vari-
ability was obtained by calculating the 95th percentile
of all amplitude changes observed between baseline
measurements. The percentage amplitude difference be-
tween the first and second baseline FEOG (i.e. absolute
value of the difference divided by the first measure) was
calculated for each subject. One subject (c9) had three
baseline measures; for her the differencing was done in
Fig. 3. Ratio of FEOG amplitude (left) and mean voltage (right)
post-glucose to pre-glucose for each of the nine subjects. Each symbol
represents a subject. Solid line represents no difference post- versus
pre-glucose. Dashed line represents the estimated amount of non-glu-
cose-associated FEOG amplitude variation expected to occur during
a test session. Solid horizontal line at unity represents no difference
between pre and post glucose.
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a pairwise fashion. The 95th percentile of the changes
for all observers was 12%. Based on our two estimates,
a conservative value of 15% was chosen (dashed line
Fig. 3) as our estimate of non-glucose associated varia-
tion in FEOG amplitude over time. The amplitude
increases of all but one subject were larger than this.1
What is the basis of the FEOG amplitude increase?
Three possibilities are apparent: an increase in peak
voltage during the dark phase, a decrease in the
‘trough’ voltage during the light phase, or a change in
both the light trough and the dark peak. To examine
this, the mean voltage measured during each 10-min
FEOG recording was calculated for each subject. The
means of the included pre-glucose and post-glucose
recordings were then computed for each subject. The
data set on the right in Fig. 2 plots the ratio of post- to
pre-glucose mean voltage for each individual. In con-
trast to FEOG amplitude (left), which increased sub-
stantially and systematically following glucose in-
gestion, mean FEOG voltage did not show systematic
variation across blood glucose levels. A few observers
had slightly higher mean voltages post glucose, most
showed no change, and a few showed lower voltages
than at pre-glucose. Further comparisons show no sys-
tematic association between mean voltage and FEOG
amplitude or in terms of relative magnitude of the
glucose-associated effect. Thus, the association between
FEOG amplitude and glucose level is independent of
mean voltage. Further evidence for this independence is
that the findings are unchanged if FEOG amplitude is
‘corrected for’ (divided by) mean voltage for each indi-
vidual both pre and post-glucose. For this derived ratio
measure the mean difference between pre- and post
glucose is 27.6%, very close to the ‘raw’ FEOG values.
These results suggest that the amplitude increase ob-
served most likely reflects a nearly symmetrical increase
in the dark peak height and the light trough depth.
That this is the case can be seen in the example in Panel
1C, which shows the averaged pre-glucose and averaged
post-glucose FEOG’s of subject c9. The curves have
not been vertically shifted with respect to one another.
The large and nearly-symmetrical increase in dark peak
and decrease in light trough voltages, with no underly-
ing change in mean voltage, is apparent.
4. Discussion
Existing evidence indicates that the fast-oscillation of
the electro-oculogram (FEOG) is generated by light-
evoked changes in RPE chloride concentration, which,
in turn, produce a decrease in basal membrane Cl
conductance and concomitant basolateral membrane
hyperpolarization (Bialek et al., 1995; Gallemore &
Steinberg, 1993). Here we have shown that large in-
creases in the amplitude of the FEOG accompany
increases in blood glucose in normals. FEOG changes
induced by acutely elevated glucose may thus reflect
alterations in RPE function and, more specifically, ion
transport processes related to fluid transport in the
retina-to-choroid direction.
The glucose associated change in the FEOG appears
to be symmetrical, with the light trough and dark peak
both increasing to produce the observed amplitude
increase. The data further suggest that the mean
recorded voltage, and thus the standing potential of the
eye, did not change following glucose ingestion. Rather,
only the relatively fast processes that are modulated by
light and dark are altered. This suggests that the FEOG
amplitude changes do not reflect the growth of an
underlying ‘EOG light-peak’. It also indicates that the
variation in FEOG amplitude is not attributable to
glucose-associated variation in extraneous factors, such
as skin resistance, volume conductance through ex-
traocular tissues, or other factors that may affect elec-
trode impedance and simply amplify the voltage signal.
It is also unlikely that these changes are secondary to
osmotic effects related to increased glucose, as they are
of opposite polarity (Macaluso, Onoe, & Niemeyer,
1992; Kawasaki, Yonemura, & Madachi-Yamamoto,
1984).
The events which lead to generation of the FEOG
begin with photoreceptor light and dark responses with
subsequent changes of potassium concentration in the
sub-retinal space. Rod responses are likely to make the
major contribution to this initial event (Weleber 1989;
Rabin, 1991). To our knowledge, a cone response con-
tribution to initiation of the fast oscillation has not
been established. However, we find no change in FEOG
amplitude with large increases (1.3 log units) in back-
ground light level within the photopic range, consistent
with absence of cone involvement (data not shown). As
part of a separate study, we have used the ERG to
measure the sensitivity of retina to increased blood
glucose concentration (Schneck, Fortune, & Adams,
1999). We found that dark adapted rod responses (a-
waves) are affected little, if at all, by glucose changes
like those induced here. Thus, the glucose effect is likely
to be further downstream, within the RPE, consistent
with the results of Macaluso et al. (1992) in vitro. They
showed, in recordings in isolated perfused cat eyes
showed that the fast P-III (and hence the rod photore-
1 Similar systematic changes with blood glucose were found for the
peak to trough voltage ratio, another ERG parameter used by
investigators (e.g. Nakao et al., 1995; Weleber, 1989). All subjects
showed larger peak to trough ratios post-glucose, with changes
ranging from 0.01 to 0.16. The mean peak to trough ratio pre-glucose
for all subjects was 1.20 (S.D. 0.03, range 1.15–1.32), while the post
glucose mean was 1.25 (S.D. .04, range 1.19–1.36). The apparently
small size of these changes is misleading, as they reflect large absolute
voltage changes. The peak to trough ratios are very similar to those
reported in normal subjects by Weleber (1989).
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ceptors) are insensitive to changes in glucose concentra-
tion and showed further evidence that the measured
glucose-associated changes in light-evoked potentials
originating in outer retina are attributable to alterations
in the RPE. Assessing the glucose effects on the c-wave
(as Macaluso et al. were able to do in cat eyes) would
further localize the glucose-dependence; however, c-
wave recordings in alert humans were unreliable.
The effects of BG on the human FEOG observed
here, although rapid and reversible, may occur by the
same mechanisms as the more permanent retinal and
vision changes that are well known to result from
chronic (and:or chronic acute) hyperglycemia, such
as those related to development of BRB dysfunction,
diabetic retinopathy and macular edema. Numerous
experimental diabetes studies have shown that changes
in RPE metabolism, such as reduction of Na:K ATP-
ase activity and protein synthesis, are an early con-
sequence of prolonged hyperglycemia (e.g. MacGregor
& Matschinsky, 1986a,b; Dircks, Williams, &
Campochiaro, 1987).The association between glucose
and retinal:RPE function demonstrated here, using sim-
ple, non-invasive techniques, highlights the value of
studies of acute effects of blood glucose on retinal
function for understanding the more devastating retinal
consequences of diabetes.
In summary, in normal human subjects, abrupt ele-
vation of BG affects the amplitude of the FEOG, a
non-invasive (electrophysiologic) measure of outer-reti-
nal:RPE function. Alterations in the FEOG may reflect
alterations in RPE transport mechanisms and:or
metabolism that could lead to a chronic reduction in
net fluid transport across the RPE. Such alterations
may be contribute to the development and:or persis-
tence of macular edema, a major cause of sight loss in
diabetes. The question remains whether diabetics and
non-diabetics differ in terms of their responses to this
simple metabolic challenge.
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